TONE NOTES · A MELASMA READING GUIDERESEARCHED OCTOBER 2026
tone●notes
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
SHORT-CONTACT CREAM

Cyspera Intensive review

A current 7% cysteamine rinse-off cream, with older clinical research kept in its proper context.

Current listed active
Cysteamine 7%
Price
$180 on the official US page
Format
Rinse-off, not an overnight leave-on cream

Use the current formula when comparing

The product page specifies 7% cysteamine and includes isobionic-amide in the formulation. The ingredient list also contains glycolic acid and fragrance. Those details distinguish this preparation from a single-ingredient experiment.[source]

A reader should not leave the cream on overnight merely because other pigment treatments are used that way. Follow its current label and obtain professional guidance about how it fits any existing prescribed care.

A 5% trial cannot be relabeled as a 7% product trial

The selected primary study examined a 5% cysteamine preparation against 4% hydroquinone in 40 women. Both groups improved; some measured outcomes favored hydroquinone. The study also involved sun protection.[source]

That finding is relevant background for discussing cysteamine. It does not establish identical performance of today’s Intensive formula, prove that a higher percentage wins or support transferring one trial’s response to every user.

A different format still needs tolerability review

The US page shows $180, with shipping calculated at checkout. Confirm quantity and current purchase terms before comparing cost with a prescription supply period.[source]

Hydroquinone-free should be understood as an ingredient distinction, not a guarantee of safety for every circumstance. Discuss pregnancy, an existing eruption or persistent irritation with a qualified professional. The product’s short-contact format and full ingredient list are as relevant to a shortlist as its cysteamine concentration.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. Cyspera: Intensive US product pageOfficial source; checked October 8, 2026 · Checked October 8, 2026
  2. Lima et al.: 5% cysteamine versus 4% hydroquinone2020 trial; 40 women; not a trial of the current 7% Cyspera Intensive formula · Checked October 8, 2026

Keep reading